1. Home
  2. SCYX vs DAIO Comparison

SCYX vs DAIO Comparison

Compare SCYX & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$5.14

Market Cap

37.0M

Sector

Health Care

ML Signal

HOLD

Logo Data I/O Corporation

DAIO

Data I/O Corporation

HOLD

Current Price

$3.20

Market Cap

29.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCYX
DAIO
Founded
1999
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
37.0M
29.7M
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
SCYX
DAIO
Price
$5.14
$3.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$5.22
AVG Volume (30 Days)
239.4K
44.2K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
61.36
N/A
EPS
N/A
N/A
Revenue
$257,000.00
$21,500,000.00
Revenue This Year
N/A
$4.51
Revenue Next Year
$608.78
$30.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$2.16
52 Week High
$5.62
$4.49

Technical Indicators

Market Signals
Indicator
SCYX
DAIO
Relative Strength Index (RSI) 62.82 51.20
Support Level $0.65 $3.03
Resistance Level $5.58 $3.29
Average True Range (ATR) 0.44 0.22
MACD 0.03 0.04
Stochastic Oscillator 85.57 77.08

Price Performance

Historical Comparison
SCYX
DAIO

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About DAIO Data I/O Corporation

Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.

Share on Social Networks: